✓ Betalning med kreditkort återställd — säker kassahantering via Privacy Shield

Cyblex MV

✅ Manages blood sugar
✅ Triple action formula
✅ Controls diabetes effectively
✅ Combination therapy
✅ Improves insulin sensitivity

Cyblex MV contains Metformin, Gliclazide and Voglibose.

Medicinskt granskad av Morgan Ellis — Apoteksforskare · 8 års erfarenhet  · Senast granskad: maj 2026

Köp mer, spara mer Pris per tablett
30 tabletter
US$2.10/tablet
US$63.00
60 tabletter
US$1.88/tablet · save 10%
US$113.00
90 tabletter
US$1.67/tablet · save 21%
US$150.00
180 tabletter BÄSTA VÄRDET
US$1.36/tablet · save 35%
US$245.00
Krypterad kassa
Kryptobetalning ger 10% rabatt
Diskret världsomspännande leverans
1 400+ kunder · 50+ länder

⚡ Quick Answer — What is Cyblex MV?

Cyblex MV är en triple-drug fixed-dose combination of metformin, gliclazide and voglibose (Metformin 500 mg + Gliclazide 80 mg + Voglibose 0.2 mg) used for type 2 diabetes not controlled on dual therapy. Three complementary mechanisms in a single tablet: metformin reduces hepatic glucose production; gliclazide (a second-generation sulfonylurea) stimulates insulin release; voglibose slows intestinal carbohydrate absorption to blunt post-meal spikes. Typical HbA1c reduction: 2.0–2.5 points. Usual dose: one tablet 1–3 times daily with the first bite of each main meal. Side-effect profile combines hypoglycaemia risk (gliclazide), GI flatulence/bloating (voglibose), and metformin GI upset. Hypoglycaemia rescue requires glucose (dextrose) tablets, not table sugar (voglibose blocks sucrose breakdown). Avoid in type 1 diabetes, eGFR < 30, IBD, severe hepatic impairment, and sulfa allergy.

Vad du får med MedsBase: WHO-GMP-certifierad tillverkare · Diskret förpackning · Världsvid leverans · 1 400+ verifierade kundrecensioner

📦 Varje beställning omfattas av vår Reshipment Assurance Policy — om din försändelse inte anländer inom 20 arbetsdagar, skickar vi om den.

Varför beställa från MedsBase

Våra generiska läkemedel kommer från WHO-GMP-certifierade tillverkare och skickas världsvidt i diskreta, enkla förpackningar — inget läkemedelsnamn på försändelsens utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdrag visar en reglerad kortbetalningsprocessor — aldrig “MedsBase” eller något läkemedelsnamn). Krypto och SEPA-banköverföring accepteras också. Varje beställning backas upp av vår Reshipment Assurance Policy.

What Is Cyblex MV?

Cyblex MV is an oral fixed-dose combination tablet containing three active antidiabetic ingredients: metformin, gliclazide and voglibose (Metformin 500 mg + Gliclazide 80 mg + Voglibose 0.2 mg). Manufactured by WHO-GMP certified manufacturer. Available in packs of 30, 60, 90 or 180 tablets. It is used in adults with type 2 diabetes when dual therapy is not enough and the clinician wants to intensify oral treatment before starting insulin.

The three-way combination is especially useful in people with a predominantly carbohydrate-rich diet (Asian populations) where post-meal glucose spikes are a major driver of HbA1c.

How Does Cyblex MV Work?

Cyblex MV targets hyperglycaemia through three completely separate mechanisms:

  • Metformin — reduces hepatic glucose production (activates AMPK), improves insulin sensitivity in muscle/fat, slightly slows intestinal glucose absorption. Does not cause hypoglycaemia on its own.
  • Gliclazide — a second-generation sulfonylurea. Closes KATP channels on pancreatic beta cells, triggering insulin release. Gliclazide has the best cardiovascular-safety profile in its class (ADVANCE trial).
  • Voglibose — an alpha-glucosidase inhibitor that slows carbohydrate breakdown in the gut, reducing the post-meal glucose spike. Acts locally in the gut lumen; minimal systemic effect.

Combined HbA1c reduction: 2.0–2.5 percentage points. The combination covers fasting, post-meal, and overall insulin-resistance contributions to hyperglycaemia in one tablet.

Dosage and Administration

Usual dose: one tablet taken with the first bite of each main meal (once, twice, or three times daily depending on prior regimen and HbA1c target).

  • Take with the first bite — voglibose must be ingested with food to act; gliclazide needs a meal to avoid hypoglycaemia; metformin is best tolerated with food.
  • Skip the dose if you skip the meal — especially important because of the gliclazide component.
  • Hypoglycaemia rescue: always use pure glucose (dextrose) tablets or gel, not table sugar or fruit juice — voglibose blocks sucrose breakdown in the gut.
  • Renal dosing: avoid if eGFR < 30. Reduce dose if eGFR 30–45.
  • Hold for IV contrast, surgery, or acute illness with dehydration.
  • Monitor glucose, HbA1c, weight, renal function, and vitamin B12 annually.

Biverkningar

From metformin (first 1–2 weeks): diarrhoea, nausea, abdominal cramps, metallic taste.

From gliclazide:

  • Hypoglycaemia — gliclazide has the lowest hypoglycaemia risk among sulfonylureas, but it is still possible.
  • Modest weight gain (1–2 kg)
  • Occasional skin rash

From voglibose: flatulence, bloating, soft stools, diarrhoea — usually improves with slow titration.

Uncommon but serious: lactic acidosis (metformin) — very rare, almost always in AKI/sepsis/hypoxia; severe or prolonged hypoglycaemia; hepatic-enzyme elevation; rare haemolytic anaemia in G6PD deficiency.

Läkemedelsinteraktioner

  • Raise hypoglycaemia risk: insulin, other antidiabetics, alcohol, trimethoprim/sulfamethoxazole, fluconazole, clarithromycin, ACE inhibitors, high-dose salicylates, non-selective beta-blockers (also mask symptoms).
  • IV iodinated contrast — hold pre- and post-procedure if eGFR < 60.
  • Carbonic anhydrase inhibitors (acetazolamide, topiramate) — raise lactic acidosis risk.
  • Cationic drugs (cimetidine, dolutegravir, ranolazine) — raise metformin levels.
  • Digestive enzyme preparations — counteract voglibose; avoid.
  • Corticosteroids, thiazides, thyroid hormones, oral contraceptives, atypical antipsychotics, phenytoin, rifampicin — may reduce glucose-lowering effect.

Who Should Not Take Cyblex MV?

  • Type 1 diabetes mellitus or diabetic ketoacidosis
  • Severe renal impairment (eGFR < 30)
  • Severe hepatic impairment
  • Inflammatory bowel disease or chronic intestinal obstruction
  • Sulfonamide (sulfa) allergy
  • Acute illness with tissue-hypoxia risk
  • Pregnancy and breastfeeding
  • Known hypersensitivity to any component

Förvaring

Store Cyblex MV below 25°C in a dry place. Keep out of reach of children.

Vanliga frågor

Why a triple-drug diabetes tablet?

To simplify the regimen. Patients needing metformin + sulfonylurea + alpha-glucosidase inhibitor would otherwise take three separate tablets at each meal. Combining them into one tablet improves adherence and reduces pill burden without changing the clinical effect.

If I get low blood sugar, can I just eat a sweet?

No — take pure glucose (dextrose) tablets or gel. Because Cyblex MV contains voglibose, the alpha-glucosidase inhibitor blocks the breakdown of sucrose (table sugar) and many other complex carbohydrates, so they work too slowly for a hypo. Glucose itself is absorbed directly and works within minutes.

Does Cyblex MV cause weight gain?

Modest 1–2 kg, driven by the gliclazide component. Metformin and voglibose are weight-neutral or very slightly weight-reducing, so the net effect is usually less than sulfonylurea monotherapy.

Can I drink alcohol while taking Cyblex MV?

Moderate alcohol with food is usually safe. Avoid binge drinking — raises hypoglycaemia risk (gliclazide) and lactic acidosis risk (metformin).

Should I switch to insulin?

A decision for you and your prescriber. Insulin is essential once beta-cell function is severely reduced but has its own risks (hypoglycaemia, weight gain, injections). Triple oral therapy like Cyblex MV is often tried first in motivated patients with residual beta-cell function.

Where can I buy Cyblex MV online?

You can order Cyblex MV (Metformin 500 mg + Gliclazide 80 mg + Voglibose 0.2 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.

Related Diabetes Medications

⚕ Medical Disclaimer. This page is for informational purposes only and does not replace medical advice from a qualified healthcare professional. Triple-drug diabetes therapy carries a cumulative side-effect profile — always use under close medical supervision. Hypoglycaemia with Cyblex MV must be treated with glucose (dextrose), not table sugar.

Relaterade alternativ

Andra produkter inom Kroniska tillstånd som kunder även tittar på:

More options in Diabetes

Rangerade efter senaste ordervolym på MedsBase — vad andra kunder i denna kategori väljer.

Styrka

500+80+0.2 mg

Kvantitet

30 tabletter, 60 tabletter, 90 tabletter, 180 tabletter

Recensioner

Det finns inga recensioner än

Skriv en recension
Cyblex MV Cyblex MV
Betyg*
0/5
* Betyg är obligatoriskt
* Svar är obligatoriskt
Din recension
* Recension är obligatorisk
Namn
* Namn är obligatoriskt
Lägg till foton eller video i din recension

Frågor & svar

Ställ en fråga
Cyblex MV Cyblex MV
Din fråga
* Fråga är obligatorisk
Namn
* Namn är obligatoriskt
Det finns inga frågor än